Myoadenylate-deaminase gene mutation associated with left ventricular hypertrabeculation/non-compaction

被引:24
作者
Finsterer, J
Schoser, B
Stöllberger, C
机构
[1] Krankenanstalt Rudolfstiftung Wien, Dept Neurol, Vienna, Austria
[2] Friedrich Baur Inst, Munich, Germany
[3] Krankenanstalt Rudolfstiftung Wien, Internal Dept 2, Vienna, Austria
关键词
metabolic myopathy; muscle cramps; myalgia; non-compaction; cardiac involvement; cardiomyopathy;
D O I
10.2143/AC.59.4.2005215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Left ventricular hypertrabeculation (LVHT)/non-compaction, a rare myocardial abnormality and frequently associated with neuromuscular disorders, has not been reported in primary myoadenylate-deaminase (MAD) deficiency (MADD). Case report - In a 53-year-old man with easy fatigability and myalgia since boyhood, primary MADD was diagnosed based upon slightly, but recurrently elevated creatine-kinase, absent staining for MAD on muscle biopsy, markedly reduced MAD activity in the muscle homogenate, and the C34T mutation within exon 2 of the AMPD1 gene. An ambulatory ECG showed nocturnal sinus bradycardia and echocardiography thickening of the interventricular septum (20 mm) and the posterior wall (16 mm) and additionally LVHT Cardiac MRI confirmed myocardial thickening and LVHT Myocardial thickening and LVHT were regarded as causally related to the C34T mutation. Conclusion - Cardiac involvement in MADD may manifest as left ventricular myocardial thickening and LVHT MADD should be included in the list of neuromuscular disorders which are associated with LVHT.
引用
收藏
页码:453 / 456
页数:4
相关论文
共 15 条
[1]   Myoadenylate deaminase deficiency with progressive muscle weakness and atrophy caused by new missense mutations in AMPD1 gene: case report in a Japanese patient [J].
Abe, M ;
Higuchi, I ;
Morisaki, H ;
Morisaki, T ;
Osame, M .
NEUROMUSCULAR DISORDERS, 2000, 10 (07) :472-477
[2]   Muscle function during repetitive moderate-intensity muscle contractions in myoadenylate deaminase-deficient Dutch subjects [J].
de Ruiter, CJ ;
May, AM ;
van Engelen, BGM ;
Wevers, RA ;
Steenbergen-Spanjers, GC ;
de Haan, A .
CLINICAL SCIENCE, 2002, 102 (05) :531-539
[3]  
Fishbein WN, 1999, ANN NEUROL, V45, P547, DOI 10.1002/1531-8249(199904)45:4<547::AID-ANA25>3.0.CO
[4]  
2-L
[5]  
FISHBEIN WN, 2002, ENCY MOL MED, V3, P2187
[7]   Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure [J].
Loh, E ;
Rebbeck, TR ;
Mahoney, PD ;
DeNofrio, D ;
Swain, JL ;
Holmes, EW .
CIRCULATION, 1999, 99 (11) :1422-1425
[8]   Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle [J].
Norman, B ;
Mahnke-Zizelman, DK ;
Vallis, A ;
Sabina, RL .
JOURNAL OF APPLIED PHYSIOLOGY, 1998, 85 (04) :1273-1278
[9]   Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study [J].
Rico-Sanz, J ;
Rankinen, T ;
Joanisse, DR ;
Leon, AS ;
Skinner, JS ;
Wilmore, JH ;
Rao, DC ;
Bouchard, C .
PHYSIOLOGICAL GENOMICS, 2003, 14 (02) :161-166
[10]   Myoadenylate deaminase deficiency - A common inherited defect with heterogeneous clinical presentation [J].
Sabina, RL .
NEUROLOGIC CLINICS, 2000, 18 (01) :185-+